UBS Group
BIOS

UBS Group’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

UBS Group’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,828
Closed -$19.5K – 10229
2023
Q2 		$19.5K Buy
+1,828
New +$19.2K ﹤0.01% 6881
2023
Q1 		– Sell
-1,160
Closed -$11.9K – 11030
2022
Q4 		$11.9K Sell
1,160
-23,090
-95% -$234K ﹤0.01% 8342
2022
Q3 		$243K Sell
24,250
-500
-2% -$5K ﹤0.01% 4917
2022
Q2 		$247K Sell
24,750
-250
-1% -$2.48K ﹤0.01% 4755
2022
Q1 		$247K Buy
+25,000
New +$247K ﹤0.01% 5199

Other funds holding BIOS

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.07B AUM 26.02% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return